| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/13/2008 | CN100367953C Quercetin solid liposome nano particle preparation and its preparing method |
| 02/13/2008 | CN100367948C Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/12/2008 | US7329761 Substituted imides |
| 02/12/2008 | US7329755 especially naphthalene sulfonamides, used for treating asthma |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329731 Soluble T cell receptor |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329648 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 02/12/2008 | US7329511 Nucleic acid encoding GAD65 |
| 02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 02/12/2008 | US7329409 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections |
| 02/12/2008 | CA2496623C Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives |
| 02/12/2008 | CA2488011C External preparations for treating dermatitis |
| 02/12/2008 | CA2387018C Chemokine receptor |
| 02/12/2008 | CA2315532C Cyclopeptide derivatives with integrin inhibitor properties |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2275259C Formulations of recombinant papillomavirus vaccines |
| 02/12/2008 | CA2234716C Peptides for treatment of inflammation and shock |
| 02/12/2008 | CA2208672C Immunotherapeutic imides/amides and their use for reducing levels of tnf.alpha. |
| 02/12/2008 | CA2163196C Regulation of antigen presentation |
| 02/12/2008 | CA2151732C Stable lyophilized pharmaceutical preparations of g-csf |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/07/2008 | WO2008016692A2 Chemical compounds |
| 02/07/2008 | WO2008016665A2 Imidazoacridine compounds for treating flt3 -mediated disorders |
| 02/07/2008 | WO2008016306A1 Non-allergenic ingredients and food products |
| 02/07/2008 | WO2008016141A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008016078A1 Method of proliferating lak cell |
| 02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 02/07/2008 | WO2008015480A2 Composition and method for modulating an immune response |
| 02/07/2008 | WO2008015374A2 Protein free formula |
| 02/07/2008 | WO2008014613A1 Multifunctional bioactive compounds |
| 02/07/2008 | WO2008014564A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | WO2008000777A3 Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use |
| 02/07/2008 | WO2007134350A8 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 02/07/2008 | WO2007113633A3 Immunogenic compositions comprising cat allergen fel dl |
| 02/07/2008 | WO2007110385A3 Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033038 Compositions of polyphenols and methods of use |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/07/2008 | US20080033028 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080032977 Alkyne-substituted pyridone compounds and methods of use |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080032927 Treatment of development-related disorders |
| 02/07/2008 | US20080032925 Method for Modulating Inflammatory Responses by Altering Plasma Lipid Levels |
| 02/07/2008 | US20080032923 Effective Use Method Of Medicaments And Method Of Preventing Expression Of Side Effect |
| 02/07/2008 | US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 02/07/2008 | US20080032384 Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton |
| 02/07/2008 | US20080032342 Chimeric immunogens |
| 02/07/2008 | US20080032283 Telomelysin/gfp-expressing recombinant virus |
| 02/07/2008 | US20080031982 Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031892 Extracellular immune stimulating agents from fungus of the genus Lentinus with high level of immune modulating activity; acquired immunodeficiency syndrome; mixture of polysaccharides comprises the monosaccharides galactose, mannose and glucose |
| 02/07/2008 | US20080031887 Conjugates for inducing targeted immune responses and methods of making and using same |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031849 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
| 02/07/2008 | CA2659875A1 Multifunctional bioactive compounds |
| 02/07/2008 | CA2659697A1 Method of proliferating lak cell |
| 02/07/2008 | CA2659542A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | CA2659473A1 Chemical compounds |
| 02/06/2008 | EP1884524A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
| 02/06/2008 | EP1884246A1 Cystatin from nematodes in the treatment of autoimmune or allergic diseases |
| 02/06/2008 | EP1883636A1 Substituted piperidine antagonist of hi receptor to be used for the treatment of rhinitis |
| 02/06/2008 | EP1883422A2 Tcr-independent activation of t cells |
| 02/06/2008 | EP1883415A2 Water insoluble helychrisum extract, process for preparing the same and uses thereof |
| 02/06/2008 | EP1883410A2 Antibody or antibody fragment coupled with an immunogenic agent |
| 02/06/2008 | EP1883302A2 Jak kinase inhibitors and their uses |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | EP0773939B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/06/2008 | CN101119743A Immunopotentiating agent |
| 02/06/2008 | CN101119730A Ointment |
| 02/06/2008 | CN101116669A 20(R)-ginsenoside composition and uses thereof |
| 02/06/2008 | CN101116667A Medicine for treating and preventing immune abnormalism disease |
| 02/06/2008 | CN101116522A Appetizing nucleic acid beverage |
| 02/06/2008 | CN100366742C IL-2 selective agonists and antagonists |
| 02/06/2008 | CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |
| 02/06/2008 | CN100366292C Recombinant porcine adenovirus vector |
| 02/06/2008 | CN100366276C Medicine for mediating blood cell to raise immunity |
| 02/06/2008 | CN100366264C Cornel extract and use thereof |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326769 Subjecting an extract of a group 1, 2, 3, 10, and/or 13 Phleum pretense to hydrophobic interaction chromatography, followed by gel filtration and optionally followed by cation exchanger chromatography; facilitate improved diagnosis of pollen allergies |
| 02/05/2008 | US7326727 Furanthiazole derivatives as heparanase inhibitors |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |